- Filed
- May 20, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 515.79K sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 17.9K sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $8.83M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$7.31M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $7.28M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $968K |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $40.69M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $40.65M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $53.19M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $57.01M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $20.21M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $20.35M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $37.43M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $38.32M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$13.60 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$584.45 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$13.60 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$584.45 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $4.11M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $4.9M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $3.93M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $3.73M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $10.18M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$9.42M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $1.16M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $515K |